Udayan Chatterji
Impact in
- Virology top 1%
- HIV Research and Treatment
- Hepatology top 1%
- Hepatitis C virus research
Papers in
-
- Signaling Pathways in Disease 20
- Virology 25
- HIV Research and Treatment 25
- Co-authors
- Philippe Gallay (40 shared papers)Michael Bobardt (34 shared papers)John H. Elder (8 shared papers)Aymeric de Parseval (5 shared papers)Guido David (3 shared papers)Suganya Selvarajah (3 shared papers)Grégoire Vuagniaux (5 shared papers)Precious Lim (6 shared papers)
- Journals
- PLoS ONE (10 papers)Antimicrobial Agents and Chemotherapy (8 papers)Journal of Biological Chemistry (5 papers)Journal of Hepatology (4 papers)Journal of Virology (4 papers)
- Partner nations
- United StatesSwitzerlandBelgium
In The Last Decade
Udayan Chatterji
51 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 87
- Virology 769
- Hepatology 642
- Epidemiology 789
- Infectious Diseases 372
- Immunology 419
Countries citing papers authored by Udayan Chatterji
This map shows the geographic impact of Udayan Chatterji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udayan Chatterji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udayan Chatterji more than expected).
Fields of papers citing papers by Udayan Chatterji
This network shows the impact of papers produced by Udayan Chatterji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udayan Chatterji. The network helps show where Udayan Chatterji may publish in the future.
Co-authors
The 25 scholars most cited alongside Udayan Chatterji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 158 | |
| 2 | 2010 | 143 | |
| 3 | 2006 | 137 | |
| 4 | 2007 | 133 | |
| 5 | 2010 | 96 | |
| 6 | 2004 | 88 | |
| 7 | 2005 | 76 | |
| 8 | 2008 | 70 | |
| 9 | 2005 | 64 | |
| 10 | 2000 | 63 | |
| 11 | 2012 | 53 | |
| 12 | 2012 | 48 | |
| 13 | 2006 | 47 | |
| 14 | 2014 | 45 | |
| 15 | 2004 | 44 | |
| 16 | 2015 | 44 | |
| 17 | 2011 | 43 | |
| 18 | 2019 | 41 | |
| 19 | 2010 | 39 | |
| 20 | 2004 | 39 |
About Udayan Chatterji
Udayan Chatterji is a scholar working on Molecular Biology, Virology, Hepatology, Epidemiology and Immunology, having authored 51 papers that have together received 2.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (25 papers), Hepatitis C virus research (21 papers), Signaling Pathways in Disease (20 papers), Hepatitis B Virus Studies (12 papers), Herpesvirus Infections and Treatments (6 papers), Viral Infections and Immunology Research (5 papers), Immune Cell Function and Interaction (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). The work is most often cited by research in Virology (769 citations), Hepatology (642 citations), Epidemiology (789 citations), Infectious Diseases (372 citations) and Immunology (419 citations). Udayan Chatterji has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include Philippe Gallay, Michael Bobardt, John H. Elder, Aymeric de Parseval, Guido David, Suganya Selvarajah, Grégoire Vuagniaux, Precious Lim, Tanya Parkinson and Lot D. de Witte. Their work appears in journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy, Journal of Biological Chemistry, Journal of Hepatology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.